← Latest
Brief

Karyopharm Files for Bankruptcy, Picks Ayrmid

Karyopharm filed for Chapter 11 with Ayrmid as lead bidder, whose offer is undisclosed and whose 2025 bluebird bio bid stalled without financing.

Share ↗
Karyopharm Therapeutics sign on a wall
Image: Endpoints News

Next edition

Anthropic Made $17 Billion, Then Lost Money

AI Secret

AI Secret Membership

Choose your edge.

Independent AI analysis. Your own agent to take it further.

AI Secret

AI Secret Membership · Step 1 of 2

Your next chapter starts here.

Enter your email to choose your membership. Use the same email if you already read AI Secret.

Already a member? Sign in

AI Secret

Your free daily briefing

Check your inbox.

We've sent a confirmation link to . Follow the link to verify your email and complete your free subscription.

Free membership includes the daily briefing. Paid Deep Dives require a paid membership.